Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romain Modzelewski

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|March 15, 2019
Radiotherapy boost in patients with hypoxic lesions identified by <sup>18</sup>F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome without toxicity? [RTEP5 long-term follow-up]Pierre Vera, Sorina-Dana Mihailescu, Justine Lequesne, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2010
αvβ3 imaging can accurately distinguish between mature teratoma and necrosis in 18F-FDG-negative residual masses after treatment of non-seminomatous testicular cancer: a preclinical studyNicolas Aide, Mélanie Briand, Pierre Bohn, et al.
Biomolecules|March 25, 2020
Development of Novel <sup>111</sup>-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid TumoursBenjamin Poret, Laurence Desrues, Marc-André Bonin, et al.
EJNMMI Research|March 8, 2014
Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET/CT images in patients with oesophageal cancerPierre Vera, Bernard Dubray, Odré Palie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 25, 2024
HaN-Seg: The head and neck organ-at-risk CT and MR segmentation challengeGašper Podobnik, Bulat Ibragimov, Elias Tappeiner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 14, 2014
Delineation of small mobile tumours with FDG-PET/CT in comparison to pathology in breast cancer patientsSébastien Hapdey, Agathe Edet-Sanson, Pierrick Gouel, et al.
Cancers|August 27, 2021
First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung CancerSébastien Thureau, Nicolas Piton, Pierrick Gouel, et al.
EJNMMI Research|July 1, 2026
Automatic lesion segmentation in ⁶⁸Ga-PSMA PET/CT and ¹⁷⁷Lu-PSMA SPECT/CT: added value of PET-guided SPECT in a bicentric studySolène Perret, Léa Albe, Agathe Edet-Sanson, et al.
European Journal of Haematology|February 14, 2014
Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapyVincent Camus, Helene Lanic, Jerôme Kraut, et al.
Frontiers in Cell and Developmental Biology|May 3, 2021
Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in GlioblastomaVadim Le Joncour, Pierre-Olivier Guichet, Kleouforo-Paul Dembélé, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
European Journal of Nuclear Medicine and Molecular Imaging|March 15, 2019
Radiotherapy boost in patients with hypoxic lesions identified by <sup>18</sup>F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome without toxicity? [RTEP5 long-term follow-up]Pierre Vera, Sorina-Dana Mihailescu, Justine Lequesne, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2010
αvβ3 imaging can accurately distinguish between mature teratoma and necrosis in 18F-FDG-negative residual masses after treatment of non-seminomatous testicular cancer: a preclinical studyNicolas Aide, Mélanie Briand, Pierre Bohn, et al.
Biomolecules|March 25, 2020
Development of Novel <sup>111</sup>-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid TumoursBenjamin Poret, Laurence Desrues, Marc-André Bonin, et al.
EJNMMI Research|March 8, 2014
Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET/CT images in patients with oesophageal cancerPierre Vera, Bernard Dubray, Odré Palie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 25, 2024
HaN-Seg: The head and neck organ-at-risk CT and MR segmentation challengeGašper Podobnik, Bulat Ibragimov, Elias Tappeiner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 14, 2014
Delineation of small mobile tumours with FDG-PET/CT in comparison to pathology in breast cancer patientsSébastien Hapdey, Agathe Edet-Sanson, Pierrick Gouel, et al.
Cancers|August 27, 2021
First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung CancerSébastien Thureau, Nicolas Piton, Pierrick Gouel, et al.
EJNMMI Research|July 1, 2026
Automatic lesion segmentation in ⁶⁸Ga-PSMA PET/CT and ¹⁷⁷Lu-PSMA SPECT/CT: added value of PET-guided SPECT in a bicentric studySolène Perret, Léa Albe, Agathe Edet-Sanson, et al.
European Journal of Haematology|February 14, 2014
Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapyVincent Camus, Helene Lanic, Jerôme Kraut, et al.
Frontiers in Cell and Developmental Biology|May 3, 2021
Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in GlioblastomaVadim Le Joncour, Pierre-Olivier Guichet, Kleouforo-Paul Dembélé, et al.
Pageof 6